Vedagopuram Sreekanth, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Bile Acids and Salts | 6 | 2021 | 353 | 1.970 |
Why?
|
Lithocholic Acid | 6 | 2021 | 27 | 1.910 |
Why?
|
Phospholipids | 5 | 2017 | 781 | 1.480 |
Why?
|
Micelles | 2 | 2021 | 203 | 0.930 |
Why?
|
Tamoxifen | 3 | 2017 | 980 | 0.760 |
Why?
|
Antineoplastic Agents | 5 | 2021 | 13655 | 0.550 |
Why?
|
Liposomes | 3 | 2015 | 758 | 0.530 |
Why?
|
Doxorubicin | 2 | 2017 | 2215 | 0.460 |
Why?
|
Models, Molecular | 3 | 2015 | 5454 | 0.450 |
Why?
|
Cholic Acid | 3 | 2017 | 34 | 0.390 |
Why?
|
Deoxycholic Acid | 3 | 2017 | 52 | 0.380 |
Why?
|
Surface-Active Agents | 2 | 2021 | 158 | 0.310 |
Why?
|
Epigenesis, Genetic | 1 | 2021 | 3639 | 0.300 |
Why?
|
Calorimetry, Differential Scanning | 3 | 2014 | 94 | 0.260 |
Why?
|
Mice, Inbred BALB C | 4 | 2021 | 6382 | 0.260 |
Why?
|
Fluorescence Polarization | 3 | 2014 | 132 | 0.250 |
Why?
|
Drug Carriers | 2 | 2021 | 692 | 0.250 |
Why?
|
Ubiquitin-Protein Ligases | 2 | 2024 | 1860 | 0.240 |
Why?
|
Transition Temperature | 2 | 2013 | 36 | 0.230 |
Why?
|
Phase Transition | 2 | 2013 | 74 | 0.230 |
Why?
|
Diagnostic Imaging | 1 | 2017 | 3507 | 0.220 |
Why?
|
Directed Molecular Evolution | 1 | 2024 | 161 | 0.220 |
Why?
|
Liver | 1 | 2017 | 7470 | 0.200 |
Why?
|
Thalidomide | 2 | 2024 | 888 | 0.200 |
Why?
|
Zinc Fingers | 1 | 2024 | 585 | 0.200 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2023 | 402 | 0.200 |
Why?
|
Membrane Fluidity | 3 | 2015 | 73 | 0.180 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 2 | 2017 | 407 | 0.170 |
Why?
|
Prodrugs | 1 | 2020 | 268 | 0.160 |
Why?
|
Drug Design | 2 | 2014 | 1078 | 0.160 |
Why?
|
Synthetic Biology | 1 | 2020 | 179 | 0.160 |
Why?
|
Telomeric Repeat Binding Protein 2 | 1 | 2017 | 18 | 0.160 |
Why?
|
Laurates | 2 | 2014 | 9 | 0.150 |
Why?
|
2-Naphthylamine | 2 | 2014 | 23 | 0.150 |
Why?
|
Biological Availability | 1 | 2017 | 396 | 0.150 |
Why?
|
1,2-Dipalmitoylphosphatidylcholine | 2 | 2014 | 43 | 0.140 |
Why?
|
Co-Repressor Proteins | 1 | 2017 | 194 | 0.140 |
Why?
|
CpG Islands | 1 | 2021 | 1170 | 0.140 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2017 | 363 | 0.140 |
Why?
|
Extracellular Matrix Proteins | 1 | 2021 | 849 | 0.140 |
Why?
|
Calcium-Binding Proteins | 1 | 2021 | 1081 | 0.130 |
Why?
|
Cell Line, Tumor | 3 | 2021 | 16665 | 0.130 |
Why?
|
Mice | 6 | 2021 | 81045 | 0.130 |
Why?
|
Rabbits | 1 | 2021 | 4886 | 0.130 |
Why?
|
Diphenylhexatriene | 1 | 2013 | 13 | 0.120 |
Why?
|
Tissue Distribution | 1 | 2017 | 2335 | 0.110 |
Why?
|
Membranes, Artificial | 1 | 2014 | 378 | 0.110 |
Why?
|
Neoplasms | 2 | 2021 | 21596 | 0.110 |
Why?
|
Animals | 6 | 2021 | 168561 | 0.090 |
Why?
|
Quinolines | 1 | 2014 | 719 | 0.090 |
Why?
|
Breast Neoplasms | 2 | 2014 | 20774 | 0.090 |
Why?
|
Hydrogels | 1 | 2014 | 723 | 0.080 |
Why?
|
Proteins | 1 | 2023 | 6096 | 0.080 |
Why?
|
Imidazoles | 1 | 2014 | 1205 | 0.080 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2023 | 11695 | 0.080 |
Why?
|
Genomics | 1 | 2022 | 5692 | 0.070 |
Why?
|
Disease Progression | 2 | 2021 | 13256 | 0.070 |
Why?
|
Reactive Oxygen Species | 1 | 2013 | 2077 | 0.070 |
Why?
|
Cell Cycle | 1 | 2013 | 2964 | 0.060 |
Why?
|
Rats | 1 | 2021 | 24265 | 0.060 |
Why?
|
Nerve Tissue Proteins | 1 | 2017 | 4465 | 0.060 |
Why?
|
Breast | 1 | 2013 | 1958 | 0.060 |
Why?
|
Drug Delivery Systems | 1 | 2014 | 2217 | 0.060 |
Why?
|
Nanoparticles | 1 | 2014 | 1902 | 0.060 |
Why?
|
Colonic Neoplasms | 1 | 2014 | 2542 | 0.050 |
Why?
|
Biology | 1 | 2023 | 292 | 0.050 |
Why?
|
Cryoelectron Microscopy | 1 | 2024 | 573 | 0.050 |
Why?
|
Molecular Structure | 2 | 2014 | 1907 | 0.040 |
Why?
|
Ubiquitination | 1 | 2024 | 1011 | 0.040 |
Why?
|
Gene Expression Regulation | 1 | 2017 | 12071 | 0.040 |
Why?
|
Insulin Infusion Systems | 1 | 2020 | 212 | 0.040 |
Why?
|
Zinc | 1 | 2020 | 683 | 0.030 |
Why?
|
Fatty Acids | 1 | 2023 | 1806 | 0.030 |
Why?
|
Cell Line | 2 | 2020 | 15994 | 0.030 |
Why?
|
Thermography | 1 | 2014 | 67 | 0.030 |
Why?
|
Dimerization | 1 | 2015 | 893 | 0.030 |
Why?
|
Cell Culture Techniques | 1 | 2020 | 1670 | 0.030 |
Why?
|
Thermodynamics | 1 | 2014 | 594 | 0.030 |
Why?
|
Humans | 9 | 2024 | 742088 | 0.030 |
Why?
|
Molecular Weight | 1 | 2014 | 2255 | 0.030 |
Why?
|
Injections, Intravenous | 1 | 2014 | 1420 | 0.030 |
Why?
|
Coloring Agents | 1 | 2014 | 565 | 0.030 |
Why?
|
Cell Proliferation | 2 | 2020 | 10472 | 0.030 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2014 | 731 | 0.030 |
Why?
|
Female | 4 | 2021 | 379592 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2014 | 2085 | 0.020 |
Why?
|
Nanotechnology | 1 | 2014 | 709 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 2014 | 3133 | 0.020 |
Why?
|
Temperature | 1 | 2014 | 2207 | 0.020 |
Why?
|
Polymers | 1 | 2014 | 1618 | 0.020 |
Why?
|
Cell Survival | 1 | 2014 | 5872 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2017 | 7721 | 0.010 |
Why?
|
Signal Transduction | 1 | 2023 | 23387 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2014 | 19223 | 0.010 |
Why?
|